πŸ‡ΊπŸ‡Έ FDA
Patent

US 8648112

Therapeutic uses of urolithins

granted A61KA61K31/195A61K31/35

Quick answer

US patent 8648112 (Therapeutic uses of urolithins) held by The Regents of the University of California expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/195, A61K31/35, A61P, A61P35/00